Cytori Therapeutics (CYTX) Misses Q2 EPS by 14c

August 14, 2018 4:23 PM EDT

Cytori Therapeutics (NASDAQ: CYTX) reported Q2 EPS of ($0.59), $0.14 worse than the analyst estimate of ($0.45).

For earnings history and earnings-related data on Cytori Therapeutics (CYTX) click here.



Serious News for Serious Traders! Try StreetInsider.com Premium Free!

You May Also Be Interested In





Related Categories

Earnings

Related Entities

Earnings